Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: Results of a multicenter trial

Diabetes

Volumn 46, Issue 4, 1997, Pages 632-636

  Thompson, Robert G ^a   Peterson, Janet ^a   Gottlieb, Alan ^a   Mullane, John ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN DERIVATIVE; C PEPTIDE; HEMOGLOBIN A1C; PRAMLINTIDE; SUSTACAL;

ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030989049     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.4.632     Document Type: Article

References (17)

1. Cooper GSJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632, 1987
2. Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszcuk W, Prager R: Basal and stimulated plasma levels of pancreatic amylin indicate its cosecretion with insulin in humans. Diabetologia 34:52-54, 1991
3. Butler PC, Chou J, Carter B, Wang YN, Bu BH, Chang D, Chang JK, Rizza R: Effects of meal ingestion on plasma amylin concentrations in NIDDM and non-diabetic humans. Diabetes 39:752-756, 1990
4. Mitsukawa T, Takemura J, Asai J, Nakazato M, Kangawa K, Matsuo H, Matsukura S: Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes 39:639-642, 1990
5. Kahn SE, Fujimoto WY, D'Alessio DA, Ensinck JW, Porte D: Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell. Horm Metab Res 23:577-580, 1991
6. Akimoto K, Nakazato M, Matsukura S, Hayakawa K: Plasma concentration of islet amyloid polypeptide in healthy children and patients with insulin-dependent diabetes-mellitus. Acta Paediatr 82:310-311, 1993
7. Koda JE, Fineman M, Rink TJ, Dailey GE, Muchmore DB, Linarelli LG: Amylin concentrations and glucose control. Lancet 339:1179-1180, 1992
8. Kolterman OG, Gottlieb A, Moyses C, Colburn W: Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18:1179-1182, 1995
9. Young AA, Vine W, Gedulin BR, Pittner R, Janes S, Gaeta LSL, Percy A, Moore CX, Koda JE, Rink TJ, Beaumont K Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin. Drug Dev Res 37:231-248, 1996
10. Kolterman OG, Schwarte S, Corder C, Levy B, Klaff L, Peterson J, Gottlieb A: Effect of 14 days subcutaneous administration of the human amylin analog, pramlintide (AC 137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. Diabetologia 39:492-499, 1996
11. Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802, 1988
12. Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341-346, 1984
13. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
14. The DCCT Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
15. MacDonald I, King P, Kong M-F, Stubbs T, Perkins A, Moyses C, Tattersall R: Infusion of the human amylin analogue, AC137, delays gastric emptying in men with IDDM (Abstract). Diabetologia 38 (Suppl. 1):A32, 1995
16. Brown K, Menius A, Sandefer E, Edwards J, James M: The effects of amylin on changes in plasma glucose and gastric emptying following an oral glucose load in conscious dogs (Abstract). Diabetes 43 (Suppl. 1):172A, 1994
17. Young AA, Gedulin B, Vine W, Percy A, Rink TJ: Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38:642-648, 1995